” This case study is on a 14-year-old patient diagnosed with a very aggressive form of ALL (positive for the Philadelphia chromosome mutation). A standard bone marrow transplant, aggressive chemotherapy and radiation therapy were revoked, with treatment being deemed a failure after 34 months.
Without any other solutions provided by conventional approaches aside from palliation, the family administered cannabinoid extracts orally to the patient.
Cannabinoid resin extract is used as an effective treatment for ALL with a positive Philadelphia chromosome mutation and indications of dose-dependent disease control.
The clinical observation in this study revealed a rapid dose-dependent correlation.”